221 related articles for article (PubMed ID: 10133463)
1. Target drug monitoring: a cost-effective service provided by staff pharmacists.
Chrymko MM; Meyer JD; Kelly WN
Hosp Pharm; 1994 Apr; 29(4):347, 350-2. PubMed ID: 10133463
[TBL] [Abstract][Full Text] [Related]
2. Designing drug-usage evaluation to meet Joint Commission requirements.
Peroutka JA
Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
[TBL] [Abstract][Full Text] [Related]
3. Meeting JCAHO drug usage evaluation requirements in a small hospital.
Moline KA
Hosp Pharm; 1990 May; 25(5):486-8, 492. PubMed ID: 10104827
[TBL] [Abstract][Full Text] [Related]
4. How to develop a successful DUE (drug usage evaluation) program: experience of a teaching medical center.
Cheung MO
Hosp Formul; 1994 Feb; 29(2):137-9, 142-3, 145. PubMed ID: 10131876
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive drug-use evaluation program in a health maintenance organization.
Cotterell CC; Dombroske L; Fischermann EA
Am J Hosp Pharm; 1991 Aug; 48(8):1712-7. PubMed ID: 1897551
[TBL] [Abstract][Full Text] [Related]
6. A simplistic approach to establishing drug usage/quality assurance programs.
Adachi W
Hosp Pharm; 1990 Jun; 25(6):541-4, 546-50, 555-9. PubMed ID: 10104830
[TBL] [Abstract][Full Text] [Related]
7. How a CQI program improved aminoglycoside use in a community hospital.
Wade WE; McCall CY
Hosp Formul; 1995 Feb; 30(2):114-6. PubMed ID: 10140350
[TBL] [Abstract][Full Text] [Related]
8. Development and implementation of a comprehensive, criteria-based drug-use review program.
Todd MW; Keith TD; Foster MT
Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
[TBL] [Abstract][Full Text] [Related]
9. Impact of a pharmacist/physician cooperative target drug monitoring program on prophylactic antibiotic prescribing in obstetrics and gynecology.
Michael KA; Henderson PL; Newman RB; Blackwelder EN; Caldwell RD
Hosp Pharm; 1992 Mar; 27(3):213-6. PubMed ID: 10116721
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the value, accuracy, and operational feasibility of DUE criteria.
Ben-Joseph R; Segal R; Russell WL; Oh T
Formulary; 1995 May; 30(5):280-3. PubMed ID: 10151727
[TBL] [Abstract][Full Text] [Related]
11. Strategy for developing a safe and cost-effective H2-receptor antagonist program.
Quercia RA; Chow MS; Jay GT; Quintiliani R
Hosp Formul; 1991 Nov; 26 Suppl D():20-4. PubMed ID: 10136561
[TBL] [Abstract][Full Text] [Related]
12. Warfarin: a quality assurance model for concurrent drug monitoring.
Mattei TJ; Karnack CM; Rihn TL; Eder RA
Hosp Pharm; 1985 Apr; 20(4):235-7, 240-1. PubMed ID: 10270729
[TBL] [Abstract][Full Text] [Related]
13. Documenting concurrent clinical pharmacy interventions.
Haslett TM; Kay BG; Weissfellner H
Hosp Pharm; 1990 Apr; 25(4):351-5, 359. PubMed ID: 10104389
[TBL] [Abstract][Full Text] [Related]
14. The JCAHO Agenda for Change: what changes in pharmacy and P & T activities do you need to prepare for in 1994?
Doherty EC
Hosp Formul; 1994 Jan; 29(1):54-6, 58-60, 64 passim. PubMed ID: 10131267
[TBL] [Abstract][Full Text] [Related]
15. The integration of quality assessment and a patient-specific intervention/outcomes program.
Mutnick AH; Sterba KJ; Szymusiak-Mutnick BA
Pharm Pract Manag Q; 1998 Jan; 17(4):25-36. PubMed ID: 10174746
[TBL] [Abstract][Full Text] [Related]
16. Continuous quality assurance monitoring by staff pharmacists.
Spradling GF
Hosp Pharm; 1990 Nov; 25(11):1021-4, 1027. PubMed ID: 10108872
[TBL] [Abstract][Full Text] [Related]
17. Assuring the quality of a clinical pharmacokinetics service.
Waller DJ; Smith SR
Am J Hosp Pharm; 1986 Sep; 43(9):2184-8. PubMed ID: 3766569
[TBL] [Abstract][Full Text] [Related]
18. Revising a drug information center quality assurance program to conform to Joint Commission standards.
Moody ML
Am J Hosp Pharm; 1990 Apr; 47(4):792-4. PubMed ID: 2321654
[TBL] [Abstract][Full Text] [Related]
19. Developing and implementing guidelines to promote appropriate use of fluconazole therapy in an AIDS clinic.
Anassi EO; Egbunike IG; Akpaffiong MJ; Ike EN; Cate TR
Hosp Pharm; 1994 Jun; 29(6):576-8, 581-2, 585-6. PubMed ID: 10134178
[TBL] [Abstract][Full Text] [Related]
20. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial.
Dalton-Bunnow MF; Halvachs FJ
Hosp Pharm; 1993 Aug; 28(8):746-9, 752-5. PubMed ID: 10127575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
